Fortis Launches Institute of Genomic Medicine to Transform Healthcare

India Pharma Outlook Team | Friday, 18 April 2025

Fortis Healthcare announced that would be inaugurating the Fortis Institute of Genomic Medicine, a high-tech setup aimed at rejuvenating patient care with the facility's goal to settle genomics mainstream into clinical healthcare. The integration of genomics into patient care and subsequent use of Fortis facilities will be possible with the national network of Agilus Diagnostics.

This pioneering initiative will also encompass a multidisciplinary team of molecular hematology experts, oncology professionals, pediatricians, neurologists, pediatricians, and pathologists. This team can then be augmented by genomic, bioinformatics, and artificial intelligence applications in oncology, cardiology, and neurology.

Anil Vinayak, Group COO, Fortis Healthcare, emphasized, “The launch of the Fortis Institute of Genomic Medicine is a strategic step forward in our vision to be at the forefront of transformative healthcare. By integrating genomics into our core offerings, we are enhancing our ability to deliver personalized, data-driven care while strengthening our clinical leadership in clinical innovation. This initiative reinforces our long-term commitment to investing in future-ready technologies that improve patient outcomes, support clinical excellence, and redefine the standards of care across the healthcare ecosystem."

Dr. Ritu Garg, the Chief Innovation and Growth Officer, stated, " The launch of the Fortis Institute of Genomic Medicine is a strategic leap in our pursuit of future-ready healthcare. At Fortis, we recognize that the future of medicine lies in precision and personalization. This institute reflects our vision to integrate cutting-edge science with clinical excellence, enabling us to drive better patient outcomes and redefine standards of care. As leaders in the healthcare ecosystem, we are committed to fostering innovation that is scalable, sustainable, and deeply impactful."

In its road ahead, Fortis seeks to roll out Genomics-Inform Health Registry and the first AI-powered organization in genomic reporting in India, producing Indian clinicians and satisfying global guidelines (ACMG, AMP, ASCO) in advancing precision medicine.

© 2025 India Pharma Outlook. All Rights Reserved.